Baird analyst Catherine Schulte lowered the firm’s price target on PerkinElmer to $178 from $202 and keeps an Outperform rating on the shares. The analyst said they reported a solid 3Q beat, with organic outperformance in DAS driving the revenue upside versus her model, and again raised the organic growth outlook for 2022.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PKI: